Uterine cancer is one of the leading forms of women's malignancies worldwide, as over 417,000 people are diagnosed with it each year and 97,000 patients die from this cancer annually [1]. When discussing gynecological oncology, it should be taken into account that uterine cancer itself is not a unified condition since, mostly when speaking of it, we refer to endometrial cancer developing in the lining of the womb, but there is also uterine sarcoma. Although the problem of these malignancies is universal, Germany warrants attention due to its excellent healthcare system and its tendency to adopt innovative treatment methods.
For example, minimally invasive and robotic surgery is widely used to treat endometrial cancer in Germany. What is more, innovative forms of radiation therapy and targeted or immunotherapeutic drugs are utilized in some German clinics even at later stages of cancer.
Uterine Cancer Treatment Overview
To effectively treat cancer, understanding its origins is crucial. Different treatments have been developed to target particular stages of tumor development and cell types. Therefore, understanding a diagnosis also involves familiarity with the medical terminology used by doctors.
Endometrial Cancer, Womb Cancer, and Uterine Sarcoma
When talking about uterine cancer, it is a general term that can be used for any malignancy originating in the different layers of the uterus. The most common subtype, making up about 90% of all uterine cancers, is endometrial cancer [2]. It starts in the inner lining of the organ called the endometrium.
In different countries, like the UK and Australia, there is a patient-friendly synonym – womb cancer. Womb cancer treatment and uterine cancer treatment refer to the same medical protocols.
Uterine sarcomas describe another much rarer and more aggressive group of tumors that develop in the myometrium (the muscular wall) or the connective tissue of the uterus.
Factors That Determine Uterine Cancer Treatment
The choice of treatment for uterine cancer depends on the patient's medical case review. Even if patients have identical diagnoses, their treatments can differ significantly and depend on various circumstances. Oncologists take into account several factors and create a personalized treatment program in Germany for patients with uterine tumors [3]:
- Stage and grading: how far the disease has spread and how aggressive the cancer cells appear under the microscope. For high-risk endometrial cancer, the therapy should be more intensive.
- Histological tumor type: if the cancer is an ordinary adenocarcinoma, a rare clear cell endometrial cancer, or a uterine carcinosarcoma, this factor determines the chemotherapy, immunotherapy, or targeted therapy regimen.
- Receptors: checking for the presence of estrogen and progesterone receptors helps to understand whether hormonal therapy is applicable.
- Health condition and patient's age: overall health condition affects the possibility of undergoing a comprehensive uterine cancer surgery or less complex therapy.
With the help of an expert medical case review, doctors from leading gynecologic oncology centers in Germany can determine the exact biology of the tumor. The right clinic selection in Germany will provide you with all necessary diagnostics to consider all the above-listed factors.
Uterine Cancer Treatment by Stage in Germany
When choosing the appropriate uterine cancer treatment, the stage is one of the major influencing factors. The extent of tumor spread directly influences the aggressiveness of the therapies and whether or not organ sparing is possible.
Early-Stage Uterine Cancer Treatment in Germany
In case of early detection and localization exclusively within the uterus, the main priority for treatment is the full surgical excision of the organ. Endometrial cancer treatment in Germany at this stage entails a minimally invasive hysterectomy procedure. Since there is no evidence of tumor cell metastasis, most patients do not require additional therapy. Highly qualified and experienced uterine cancer clinics in Germany use robotic technology to achieve accurate surgery and faster recovery.
Locally Advanced Uterine Cancer Treatment in Germany
If the tumor has progressed and infiltrated the uterine wall or invaded the cervix and/or pelvic structures, treatment for uterine cancer would involve the use of multiple approaches. Post-surgery radiation therapy for uterine cancer is applied to destroy any remaining cancer cells in the pelvis. Also, systemic therapies can be added to target residual cancer cells and prevent local recurrences, lymph node involvement, or systemic spread.
Recurrent Uterine Cancer Treatment in Germany
If the illness recurs despite the initial treatment, the physicians need to change their course of action. Recurrent uterine cancer treatment entails a thorough reassessment, which may include PET-CT imaging and repeated biopsies [4]. The treatment plan for recurrent endometrial cancer could include another surgery, a new type of chemotherapy, or immunotherapy. It is important to note that if recurrent endometrial cancer has developed drug resistance to the first medication, participating in research in Germany can be a great addition for the patients and possibly a new hope for them to control their disease.
Stage 4 Uterine Cancer Treatment in Germany
In case of metastasis to distant organs such as the lungs, liver, or bones, the disease is termed stage 4. Stage 4 uterine cancer treatment is not aimed at its complete elimination but rather at its regulation, an increase in the patient’s lifespan, and an improvement in their quality of life. Such approaches to stage 4 uterine cancer treatment have been developed in Germany.
Systemic Therapy for Stage 4 Uterine Cancer in Germany
Stage 4 uterine cancer treatment in Germany is highly dependent on systemic treatment options that allow the drug to enter the whole system and help cope with the growth of cancer cells and their spread.
Chemotherapy for uterine cancer is the foundation of treatment. It targets malignancy throughout the body and helps control late-stage disease. Oncology hospitals in Germany commonly combine regular chemotherapy with advanced biological drugs or even with immunotherapy to increase the efficiency of treatment. Also, immune checkpoint inhibitors have become an integral part of the first-line regimen for metastatic endometrial cancer treatment, combined with chemotherapy. Such a double effect helps prevent cancer cells from evading the organism's natural defense system, while chemotherapy works by inhibiting mitosis. Studies have shown that the use of such modern immunotherapy, along with chemotherapy, reduces the probability of disease progression in more than 25% of cases [5].
Advanced Options for Stage 4 Uterine Cancer in Germany
In cases where advanced uterine cancer treatment is required, contemporary oncology goes beyond classic chemo. Modern stage 4 uterine cancer treatment in Germany includes molecular profiling of the cancer tissue on a deep level. In case certain genetic changes or biomarkers are detected in the tumor tissue, stage 4 endometrial cancer treatment may include very specialized targeted therapy. For example, dMMR (deficient mismatch repair) and MSI-H (microsatellite instability-high) cancer types are very sensitive to single-agent immunotherapy. Also, for stage 4 uterine cancer treatment in Germany, interventional oncology methods (such as TACE for uterine cancer metastases) can be applied to decrease the burden of the disease.
Main Uterine Cancer Treatment Options in Germany
Uterine cancer care in Germany entails a high degree of cooperation among the oncological care team. It involves a discussion in a tumor board (also known as an oncological consilium), which brings together specialists such as gynecologic oncologists, radiotherapists, molecular pathologists, and interventional radiologists to analyze the case and develop the best possible plan for uterine cancer treatment options.
The clinical system combines radical control of the area with system precision. Based on the stage and molecular characteristics of the tumor, the treatment program in Germany will include the following modalities.
Surgery for Uterine Cancer in Germany
Surgery is the cornerstone of uterine cancer treatment, and in Germany, it is performed with a strong focus on precision, safety, and women's recovery. The standard operation for most endometrial cancer cases is a total hysterectomy – removal of the uterus – often combined with bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes) to reduce the risk of recurrence.
Where Germany excels is in the use of minimally invasive methods, particularly laparoscopy and robotic-assisted surgery. These approaches require only small incisions, resulting in less blood loss, lower infection risk, and faster return to normal activities. Studies have shown that in experienced German cancer centers, minimally invasive laparoscopic hysterectomy offers comparable cancer control to open surgery while significantly improving short-term recovery.
For more advanced stages, surgeons often perform systematic lymph node dissection – carefully removing and examining pelvic and para-aortic lymph nodes to determine whether the cancer has spread. This not only helps in accurate staging but also guides the need for additional treatments such as radiotherapy or chemotherapy.
Radiation Therapy and Brachytherapy in Germany
Radiation therapy in Germany often uses highly targeted external beam radiotherapy (EBRT) to destroy tumor cells while sparing healthy tissues. Brachytherapy for uterine cancer, in which a radioactive source is placed inside or close to the tumor, is also a standard option – especially for localized cancer– helping reduce recurrence rates with minimal systemic effects [7].
Chemotherapy for Uterine Cancer in Germany
When cancer is advanced or has spread beyond the uterus, chemotherapy becomes an important component of cancer treatment in Germany. German oncology centers use modern drug combinations to maximize tumor control while managing side effects, often in combination with other therapies for a more comprehensive approach.
Hormone Therapy for Uterine Cancer in Germany
For patients with endometrial cancer, especially those with hormone-sensitive tumors, hormonal therapy remains a vital treatment option. By modulating hormones that fuel tumor growth, this therapy can slow or even halt cancer progression. Many doctors in Germany carefully evaluate the tumor’s receptor status to determine whether hormonal treatment is appropriate, making it a personalized approach tailored to each endometrial cancer case.
In addition to hormonal therapy, German clinics offer cutting-edge targeted therapies designed to attack endometrial cancer cells with specific genetic profiles. These targeted treatments provide new hope for endometrial cancer patients who may not be suitable candidates for more aggressive options such as extensive surgery or chemotherapy. For cancers originating in the womb, combining hormone-based therapy with targeted agents helps doctors improve outcomes while minimizing side effects.
Overall, the range of hormonal and targeted therapies available in Germany gives patients a variety of effective strategies to manage their endometrial cancer while preserving quality of life.
Targeted Therapy for Uterine Cancer in Germany
Targeted therapy for uterine cancer is an example of precise medicine. The standard chemotherapy drug works by inhibiting rapidly growing cells; on the other hand, the targeted drug works only by inhibiting the biochemical pathway that facilitates the growth and survival of cancerous cells. At the uterine cancer clinics in Germany, angiogenesis inhibitors and mTOR inhibitors have been proven to be useful in the advanced uterine cancer treatment.
Some of the targeted therapies include [8]:
- VEGF Inhibitors. This medication prevents tumors from forming new blood vessels. This results in a reduction in the nutrient and oxygen supply. It is often combined with standard chemo.
- HER2-targeted therapy. In a small percentage of patients who overexpress the HER2 protein, these drugs can be particularly effective.
Selected Advanced Methods for Stage 4 Uterine Cancer in Germany
Stage 4 uterine tumors demands a carefully tailored treatment strategy. In Germany, oncologists rely on a multimodal approach – combining surgery, systemic therapy, and innovative local treatments like hyperthermia for uterine cancer – to control tumor growth, alleviate symptoms, and improve life expectancy. This coordinated approach targets endometrial cancer from multiple directions, aiming to slow progression and maintain quality of life.
Dendritic Cell Therapy for Uterine Cancer in Germany
Dendritic cell therapy for endometrial cancer is a powerful form of immunotherapy that directly trains the body’s immune system to target and destroy cancer cells. Dendritic cells act as the body’s "commanders" of immunity – they capture and process tumor antigens, then present them to T-lymphocytes, triggering a highly specific and aggressive attack on malignant cells.
Dendritic cells are collected from the patient’s blood. In a specialized laboratory, they are exposed to tumor-associated antigens, essentially "educating" them to recognize the cancer. Once these trained cells are reintroduced into the patient, they travel through the body, activating cytotoxic T-cells and natural killer (NK) cells, which then seek out and destroy cancer cells wherever they are hiding.
This targeted immune activation not only attacks existing tumors but also creates a long-term immune memory, reducing the risk of recurrence.
The discovery of dendritic cells and their central role in immunity earned Ralph Steinman the Nobel Prize in Physiology or Medicine in 2011. Today, German cancer centers successfully use this therapy for advanced endometrial cancer, achieving durable responses and improved patient outcomes.
Immunotherapy for Uterine Cancer in Germany
Uterine tumor immunotherapy involves using medication that removes the brakes on the immune system imposed by cancer cells. Inhibitors of immune checkpoints work by blocking proteins such as PD-1 or PD-L1, thereby allowing the body’s T-cells to identify and target cancerous tissue. Immunotherapy for endometrial cancer is highly effective in cases with special genetic characteristics, including mismatch repair deficiency or MSI-H.
New immunotherapy for uterine cancer can be divided into several general areas, such as immune blockade, cytokine therapy, dendritic cell vaccines, and combination therapy with supportive therapy or anti-cancer therapy. Each of these new advancements targets a different aspect of the immune response to provide tailored therapy across the various stages of malignancy.
TACE for Selected Uterine Cancer Metastases in Germany
Transarterial chemoembolization (TACE) is a commonly used procedure in Germany for treating endometrial cancer metastases in the liver and other organs with a dedicated arterial blood supply. During chemoembolization, a catheter is carefully guided into the tumor’s feeding artery, where a concentrated dose of chemotherapy is delivered directly to the cancer cells. This is immediately followed by embolization with tiny particles that block the blood flow, effectively trapping the chemotherapy inside the tumor.
The combined effect of chemoembolization as a metastatic uterine cancer treatment helps starve the tumor while maximizing local drug concentration, resulting in tumor shrinkage and prolonged disease control with fewer systemic side effects.
HIPEC and PIPAC for Peritoneal Spread in Germany
In cases of peritoneal metastases from womb cancer, HIPEC is used to deliver heated chemotherapy directly into the abdominal cavity immediately after tumor removal. During the HIPEC procedure, the heated chemotherapy solution circulates throughout the abdomen, allowing doctors to target residual cancer cells more effectively. The elevated temperature (41-43°C) used in HIPEC enhances drug penetration and increases the cytotoxic effect on any remaining tumor cells.
HIPEC for uterine cancer has become a well-established and trusted treatment in Germany, with surgical oncology teams performing the procedure routinely. By combining surgery with HIPEC, doctors can achieve better local disease control and improved patient outcomes. The widespread use of HIPEC in specialized centers highlights its importance in managing advanced womb cancer.
When the peritoneal spread is extensive, when the cancer is inoperable, or when a patient is not a candidate for major open surgery, German clinics often turn to PIPAC for uterine cancer. Heavily researched and pioneered in Germany, PIPAC serves as a revolutionary, minimally invasive alternative for advanced or chemo-refractory cases. Localized physical pressure overcomes the natural fluid barriers of tumor cells, forcing the medicine to distribute evenly and penetrate much deeper into the cancerous tissue. Because PIPAC uses only 10% to 20% of a conventional systemic chemotherapy dose, plasma concentrations remain exceptionally low, resulting in minimal systemic side effects and excellent preservation of the patient's quality of life.
Hyperthermia as an Additional Method in Germany
Hyperthermia involves heating tumor tissue to weaken cancer cells and make them more susceptible to chemotherapy and radiotherapy. In leading German oncology clinics, this method is applied with precision to maximize its effect on tumors while protecting healthy tissue, often resulting in better treatment responses and longer survival.
Uterine Sarcoma Treatment in Germany
As uterine sarcoma is a rare and very aggressive form of cancer that occurs in the muscular wall or connective tissues of the uterus but not in its mucous membrane, treatment of this condition in Germany entails an extremely specialized method that is totally different from that used for endometrial tumors.
The basic point in clinical practice lies in using high-precision surgical excision with negative margins, which may be followed by special systemic treatment because sarcomas tend to be very insensitive to the standard hormone modulation. To address the peculiarities of this type of tumor and its vascular spread, specialized chemotherapy protocols are used, along with targeted biological agents and interventional techniques such as local hyperthermia or transarterial chemoembolization (TACE).
As this kind of cancer is rare and unpredictable, every treatment plan is created individually according to the results of a thorough examination performed by a tumor board consisting of gynecologic oncologists, pathologists, and radiologists.
Main Treatment Options for Uterine Sarcoma in Germany
Uterine sarcoma, including subtypes like leiomyosarcoma of the uterus, originates in the muscle or supportive tissues. These tumors rarely respond to hormone therapy and are generally managed with highly aggressive surgical resection. A hysterectomy for uterine cancer in the case of sarcoma is often more extensive.
Post-surgical care relies heavily on specific chemotherapy regimens, as radiation therapy for uterine cancer is generally used only to control local pelvic symptoms rather than to cure the systemic disease.
Uterine Cancer Treatment Cost in Germany
Understanding the uterine cancer treatment cost is vital for planning your medical journey. The uterine cancer treatment cost in Germany is strictly regulated by the G-DRG (German Diagnosis-Related Groups) system. This means the prices are based on the actual medical resources utilized – such as operating room time for a minimally invasive hysterectomy, days spent in the hospital, and the specific pharmaceutical cost of chemotherapy for uterine cancer.
Cost Comparison With Other Countries
Compared to the USA, where an unregulated market can drive advanced uterine cancer treatment bills into astronomical figures, Germany offers highly predictable and significantly lower pricing for the same or better clinical standards. While the UK, Canada, and Australia offer public healthcare, wait times for uterine cancer surgery can be dangerously long; accessing the private sector in those countries often results in higher fees than the equivalent treatment program in Germany.
Before traveling, patients can receive a preliminary cost estimate based on their medical case review. Getting a preliminary cost estimate ensures there are no hidden fees. Initiating a Booking Health uterine cancer treatment program streamlines this financial assessment. Furthermore, managing treatment in Germany for international patients means everything from translation to logistics is accounted for in the initial planning phase.
Below, we present you with a table comparing the prices for receiving oncological treatment in various countries:
Comparison of the Prices for Standard and Innovative Treatment for Uterine Cancer Worldwide
| Standard Methods | Innovative Methods | |
|---|---|---|
| Germany | €80,000 - €150,000 full course | €25,000 - €60,000 full course |
| GB | €90,000 - €165,000 full course | €70,000 - €120,000 full course |
| USA | €100,000 - €180,000 full course | €100,000 - €150,000 full course |
| Australia | €90,000 - €200,000 full course | €85,000 - €130,000 full course |
| Canada | €90,000 - €170,000 full course | €110,000 - €155,000 full course |
Booking Health Support for Uterine Cancer Treatment in Germany
Finding the best treatment strategy for your clinical situation is challenging. Being already exhausted from multiple treatment sessions, having consulted numerous specialists, and having tried various therapeutic interventions, you may be lost in all the information given by the doctors. In such a situation, it is easy to choose a first-hand option or to follow standardized therapeutic protocols with a long list of adverse effects instead of selecting highly specialized innovative treatment options.
To make an informed choice and get a personalized cancer management plan, which will be tailored to your specific clinical situation, consult medical experts at Booking Health. Being at the forefront of offering the latest medical innovations for already 12 years, Booking Health possesses solid expertise in creating complex management programs in each individual case. As a reputable company, Booking Health offers personalized uterine cancer treatment plans with direct clinic booking and full support at every stage, from organizational processes to assistance during treatment. We provide:
- Assessment and analysis of medical reports
- Development of the medical care program
- Selection of a suitable treatment location
- Preparation of medical documents and forwarding to a suitable clinic
- Preparatory consultations with clinicians for the development of medical care programs
- Expert advice during the hospital stay
- Follow-up care after the patient returns to their native country after completing the medical care program
- Taking care of formalities as part of the preparation for the medical care program
- Coordination and organization of the patient's stay in a foreign country
- Assistance with visas and tickets
- A personal coordinator and interpreter with 24/7 support
- Transparent budgeting with no hidden costs
Health is an invaluable aspect of our lives. Delegating management of something so fragile yet precious should be done only to experts with proven experience and a reputation. Booking Health is a trustworthy partner who assists you in pursuing stronger health and a better quality of life. Contact our medical consultant to learn more about the possibilities of personalized treatment with innovative methods for uterine cancer with leading specialists in this field.
Modern Cancer Treatment: Patient Journeys with Booking Health
Frequently Asked Questions of Our Patients About Uterine Cancer Treatment in Germany
There are various advanced options for uterine cancer treatments available in Germany that include surgery, radiation therapy, chemotherapy, and novel types of treatments. Patients can undergo minimally invasive hysterectomies in Germany as well as receive personalized targeted and immunotherapy treatments. Treatment regimens are created at the best oncological clinics in Germany.
The price of treating uterine cancer in Germany depends on the stage and the treatments used. Price comparisons between the best clinics in Germany allow patients to get competitive prices for surgery, radiation therapy, and systemic treatment.
It is found from the oncology statistics of Germany that the overall survival rates of womb cancer treatment in Germany are among the best in the world, particularly in the case where it has been diagnosed in the early stages.
The best uterine cancer hospital can be found among the network of certified endometrial cancer clinics in Germany, known for their multidisciplinary approach and latest treatment technologies. Patients often choose top clinics in major cities such as Berlin, Munich, and Hamburg, which are recognized internationally for excellence in gynecologic oncology.
Indeed, German oncological hospitals conduct research that provides access to experimental treatment options for patients with uterine cancer in Germany. With convenient medical tourism assistance, foreign patients can participate in the latest research and benefit from professional treatment.
Surgery is one of the main procedures that entails the removal of the uterus (hysterectomy), which is commonly supplemented by the removal of the ovaries and fallopian tubes. Other treatment procedures include chemotherapy, hormone therapy, molecular-targeted therapy, and brachytherapy for uterine cancer.
Endometrial cancer is the most prevalent form of uterine cancer (over 90% of all cases). Although often used interchangeably, the general term for cancer of the uterus also covers other rare forms, such as uterine sarcoma.
Surgery is the gold standard and the most curative option for early-stage disease using minimally invasive methods like robotic hysterectomy. However, in certain advanced cases or if a patient’s overall health prevents safe surgery, radiation combined with systemic therapies may be used as the primary treatment.
Patients whose tumors have specific genetic markers – such as mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H) – are the best candidates. In the case of dendritic cell therapy, almost everyone can benefit from this type of treatment because it is well tolerated and carries minimal side effects. It is typically used for advanced or recurrent cancer that has not responded to standard chemotherapy.
Yes. Cancer clinics in Germany apply dendritic cell therapy for uterine cancer in advanced or recurring stages to enable a person's immune system to recognize and destroy abnormal cells.
Because uterine sarcoma behaves differently from endometrial carcinoma, it is primarily treated with aggressive surgical resection. If it spreads, it is usually managed with specific chemotherapy regimens rather than hormone therapy.
Traditional full courses of treatment usually cost between €80,000 and €150,000, whereas new treatment modalities (for example, special immunotherapies) will cost an additional €25,000 to €60,000. The prices are controlled by the government.
Definitely yes. Treatment of the disease in Germany is very accessible for foreign patients. Medical tourism companies organize all procedures necessary for uterine cancer treatment abroad, including choosing the right clinic, arranging the visa, translations, and fast admission to the best cancer centers.
Choose treatment abroad and you will for sure get the best results!
Sources:
01. Tingting Feng, Wei Li, Qin Wang, Jing Yang, Fujin Shen. Global, regional, and national burden of uterine cancer among women aged 50 years and older from 1990 to 2021: a systematic analysis for the global burden of disease study 2021. J Health Popul Nutr. 2025 Jun 18;44:208. doi: 10.1186/s41043-025-00915-1. [DOI] [PMC free article]
02. Ashley S Felix, Joel L Weissfeld, Roslyn A Stone et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control. 2010 Jul 14;21(11):1851–1856. doi: 10.1007/s10552-010-9612-8. [DOI] [PMC free article]
03. Stergios Kopatsaris, Ioannis Tsakiridis, Georgios Kapetanios et al. Management of Endometrial Cancer: A Comparative Review of Guidelines. Cancers (Basel). 2024 Oct 24;16(21):3582. doi: 10.3390/cancers16213582. [DOI] [PMC free article]
04. Gözde Şahin, Ayşe HazırBulan, Işık Sözen et al. Optimizing Final Pathology Determination in Endometrial Cancer: The Role of PET/CT, MRI, and Biopsy in Serous, Mixed Cell, Clear Cell, and Grade 3 Endometrioid Subtypes. Diagnostics (Basel). 2025 Mar 14;15(6):731. doi: 10.3390/diagnostics15060731. [DOI] [PMC free article]
05. Rongxia Li, Xinmiao Zhang, Jinhai Shen. Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials. BMC Cancer. 2025 Oct 14;25:1579. doi: 10.1186/s12885-025-15039-2. [DOI] [PMC free article]
06. Dimitrios Balafoutas, Achim Wöckel, Christine Wulff, Ralf Joukhadar. Implementation of robotic gynecological surgery in a German University Hospital: patient safety after 110 procedures. Arch Gynecol Obstet. 2020 Dec;302(6):1381-1388. doi: 10.1007/s00404-020-05751-8. [DOI] [PubMed]
07. Janusz Skowronek. Current status of brachytherapy in cancer treatment – short overview. J Contemp Brachytherapy. 2017 Dec 30;9(6):581–589. doi: 10.5114/jcb.2017.72607. [DOI] [PMC free article]
08. Jonathan D Black, Diana P English, Dana M Roque, Alessandro D Santin. Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer. Womens Health (Lond). 2014 Jan;10(1):45–57. doi: 10.2217/whe.13.72. [DOI] [PMC free article]
09. Carlos Jiménez-Cortegana, Francisca Palomares, Gonzalo Alba et al. Dendritic cells: the yin and yang in disease progression. Front Immunol. 2024 Jan 4:14:1321051. doi: 10.3389/fimmu.2023.1321051. [DOI] [PubMed]
10. Wim Ceelen, Jesse Demuytere, Ignace de Hingh. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review. Cancers (Basel). 2021 Jun 22;13(13):3114. doi: 10.3390/cancers13133114. [DOI] [PubMed]
Read:
02. 4 Stage Uterine Cancer: Treatment Options for Stage 4 Endometrial Cancer
